Skin Biopsy Market Information: By Type (Shave Biopsy, Excisional Biopsy, Incisional Biopsy), Device (Needle Based Biopsy Guns, Biopsy Forceps, Biopsy Needles), Indication (Cancer, Actinic Keratosis, Skin Infection), End User - Global Forecast till 2023
Market Synopsis
The global skin biopsy market size is expected to exhibit a CAGR of 9.4% over the forecast period from 2017 to 2023, according to a new report from Market Research Future (MRFR). The global skin biopsy market is analyzed in detail in the report, which takes a look at the historical growth trajectory of the global skin biopsy market to point out key indicators of the market’s movement. Using these indicators, the report presents a detailed landscape of the skin biopsy market’s potential growth trajectory over the forecast period. The report also compiles an extended analysis on the skin biopsy market trends and key drivers as well as the key restraints likely to hold back the market over the forecast period.
Skin biopsy is a procedure involving the removal of skin for examination and providing information about any disease or clinical conditions. It is performed to determine the presence of any cancerous cells or any type of skin diseases. Skin cancer, actinic keratosis, dermatitis, psoriasis, and skin infection are various diseases that can be diagnosed through skin biopsy. During the procedure, the sample taken from the affected or diseased part of the skin is placed in formaldehyde solution, the tissue is processed and then examined under the microscope.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4650
Rising of skin cancer and number of skin disease such as psoriasis, viral skin infection, and dermatitis, and growing demand for minimally invasive medical procedures are major factors contributing to the market growth. Furthermore, rising expenditure on the medical devices and instruments boost the market growth. However, high cost of treatment for skin diseases restrains the market.
Key Players
Some of the key players in this market are Boston Scientific Corporation (U.S.), COOK Medical (U.S.), BD (U.S.), DTR Medical Ltd (U.K), Devicor Medical Products, Inc. part of Leica Biosystems. (U.S.), Gallini Srl (Italy), Hologic, Inc. (U.S.), and Cardinal Health (U.S.).
Segments
The global skin biopsy market is segmented on the basis of type, devices, indication, and end user.
On the basis of indication, the market is segmented into actinic keratosis, dermatitis, psoriasis, skin infection, cancer, and others.
Skin infection is further segmented into viral infections, deep fungal infections, basal cell carcinoma, squamous cell carcinoma, and melanoma.
On the basis of end user, the market is segmented into hospitals, dermatology clinics, and others.
On the basis of type, market is segmented into shave biopsy, punch biopsy, excisional biopsy and incisional biopsy.
On the basis of devices, the market is segmented into needle based biopsy guns, biopsy curettes and punches, guidance systems, biopsy forceps, biopsy needles and others.
Regional Analysis
America secures a leading position in the market for skin biopsy owing to the rising prevalence of skin diseases and cancer in the U.S. and presence of key market players. According to the American Academy of Dermatology (AAD), skin diseases affects one in every fourth American. The prevalence of skin diseases is also found to be increasing in Canada.
Europe is the second largest market for skin biopsy. Increasing prevalence of skin diseases such as fungal infections, and dermatitis, and increasing demand for technological advanced diagnostic services further drive the market growth.
The Middle East & Africa also show a steady rise in the market owing to increasing prevalence of diabetes and other chronic diseases
The market in Asia Pacific is expected to grow at the fastest pace and is driven by the rising geriatric population, rising prevalence of skin cancer, and increasing number of biopsies performed in the hospitals.
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/skin-biopsy-market-4650
[151 Pages Report] The Hernia Repair Market is projected to reach USD 4.75 billion, at a CAGR of 3.0% during the forecast period.Market Segmentation in Detailed:On the basis of product, the hernia repair market is segmented into mesh and mesh fixators.
In 2018, the biologic mesh segment is expected to register the highest growth rate in the hernia mesh market.
The increasing number of clinical trials to establish safety and the benefits of biologic meshes coupled with technological advancements to reduce ‘could be’ issues with this mesh are some of the factors triggering the growth of this segment.Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203245450Market DynamicsThe increasing number of hernia repair procedures, advantages of mesh in hernia repair, and technological advancements are the major factors driving the hernia repair market.
In addition, emerging markets are expected to emerge as potential areas of opportunity for players in this market.Driver: Increasing hernia prevalence;The growing prevalence of hernia is the main driving force for the growth of the hernia mesh repair market.
This is mainly attributed to the overall increase in population, specifically geriatric and obese population, and improvements in healthcare systems that have enabled the early detection and treatment of hernia.Age contributes significantly to the risk of hernia by retarding the body’s capabilities and natural healing abilities over time.
According to a registered study in the UK, the prevalence of hernia was found to increase with age, from 5% in the 25¡V34 age group to:10% in the 35-44 age group18% in the 45-54 age group24% in the 55-64 age group31% in the 65-74 age groupIn addition, the incidence of hernia among men aged 75 years and above was found to be 45%.
Maximize Market Research's latest report, " Global Surgical Imaging Market Global Demand Analysis and Opportunity Outlook 2027", offers a comprehensive analysis of the market.
It provides market segments by type and shape, as well as end-user industries and regions.Global Surgical Imaging Market was valued at US$ 1.5 Bn in 2019 and is expected to reach US$ 2.6 Bn by 2027, at a CAGR of 7.4 % during the forecast period.Global Surgical Imaging Market Overview The surgical imaging market is highly driven by growing demand for minimal invasive procedures, growing popularity of Flat Panel Detector C-arms (FPD C-arms) owing to advantages of FPDs over image intensifiers, technological advancements and high precision have increased adoption in various fields of medical sciences and availability of advanced techniques.
Moreover, reimbursement cuts on analog radiography systems, increasing demand for data integrated imaging systems, and high growth in emerging markets are the factors that will drive the market of surgical imaging market during the forecast period.On the other hand, strict approval procedures and the high cost of devices may hamper the growth of the surgical imaging market in upcoming years.
Get a Sample PDF of the Report at : Request Free Sample Report Global Surgical Imaging Market Major Market Players• GE Healthcare• OrthoScan, Inc.• Koninklijke Philips N.V.• GENORAY Co., Ltd.• Eurocolumbuss.r.l.• Ziehm Imaging GmbH• Hologic, Inc.• Shimadzu Corporation• Siemens AG• Medtronic plc• Toshiba Medical Systems Corporation• Allengers Medical Systems Ltd.• General Electric Company• Shimadzu Corporation• Hologic Inc.• OrthoScan, Inc.• Allengers Medical Systems Limited• Eurocolumbus Srl• Hologic, Inc.• Canon Medical SystemsThe Market Impact of COVID-19The COVID-19 epidemic has quickly spreaded since its inception in Wuhan (China), in December 2019.All around the globe.
This outbreak has severely affected the global food and beverage industries.This includes office closures, cancellations of technology events, and supply chain disruptions.
China is the world's largest manufacturing country and has the largest number of raw material suppliers.
Global Breast Biopsy Market: By Product (Biopsy Needles, Biopsy Tables), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy), Guidance Technology (Ultrasound-Guided, CT-Guided Biopsy), End-Users (Hospitals, Labs) –Global Forecast Till 2023Increased cancer detection rates globally have contributed to a rise in biopsy procedures.
The report covers the COVID-19 analysis of the global breast biopsy market and provides a detailed summary of market segments, current trends, growth projections, and market challenges from 2018 to 2023 (forecast period) to identify potential business opportunities.Free Sample Copy of With Considering Coivd19 Impact on this Market @ https://www.marketresearchfuture.com/sample_request/6288 A biopsy is a small operation performed to remove tissue from the area of concern within the body.
There are various types of biopsy procedures depending on the technique, such as fine needle aspiration biopsy (FNAB), core needle biopsy (CNB), and vacuum-assisted biopsy (VAB) prescribed by the doctor based on the size, location, and other characteristics of the breast abnormality.
In addition, market limitations include the high cost of surgical procedures and the complications involved.
Conversely, the advent of technologically advanced and minimally invasive breast biopsy devices is expected to create lucrative opportunities in the untapped market.
Surgical biopsy is divided into incisional biopsy and excisional biopsy.Based on guidance technology, the global market for breast biopsy has been classified into CT-guided biopsy, ultrasound-guided, mammography-guided magnetic resonance, and other image-guided breast biopsy (PET and thermography).Based on end-user, the global market for breast biopsy has been divided into hospitals, ambulatory surgical centers, diagnostic centers, and others.
The growing target patient population and the rising focus on minimally invasive surgical procedures over conventional surgery are the major factors driving the growth of this market.The report Catheters Market is Projected to Reach USD 24.2 Billion by 2025, at a CAGR of 8.7% from 2020 to 2025Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=6247803In 2019, the cardiovascular catheters segment accounted for the largest share of the market.On the basis of type, the global catheters market is segmented broadly into cardiovascular, urological, intravenous, neurovascular, and specialty catheters.
Cardiovascular catheters commanded the largest share of the catheters market in 2019 and are expected to grow at the highest CAGR during the forecast period.
This is primarily attributed to factors such as the high incidence of CVD, the growing geriatric population, and increasing awareness regarding early diagnosis.
These factors have resulted in an increase in cardiovascular surgeries, which positively impacts the cardiovascular catheters market.Hospitals to be the largest end users of cathetersBased on end user, the catheters market is segmented into hospitals, long-term care facilities, diagnostic imaging centers, and other end users.
In 2019, hospitals were the largest end users of catheters.
This segment is expected to grow at the highest CAGR, majorly due to the high volume of target procedures performed in hospitals.
